Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The GI Stool Testing Market?

The size of the gi stool testing market has seen substantial growth in the past few years. The market is projected to expand from $1.32 billion in 2024 to $1.41 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.5%. The remarkable growth in the past can be credited to a surge in gastrointestinal disease cases, growing consciousness about gut health, amplified usage of automated systems, an increase in disposable income, and a rising elderly population.

The market size for gi stool testing is projected to experience significant expansion in the coming years, eventually reaching $1.86 billion in 2029 with a compound annual growth rate (CAGR) of 7.3%. Several factors fueling this forecasted growth include the rising demand for effective diagnostic tools, increasing instances of colorectal cancer, escalating healthcare expenses, higher intake of fast food, and a growing focus on personalized medicine. The forthcoming period is likely to witness major shifts such as innovative diagnostic technologies, molecular diagnostics, advancements in biologics, personalized medicine, and strategic collaborations.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23410&type=smp

What Are The Primary Factors Supporting The GI Stool Testing Market Expansion?

An upsurge in gastrointestinal disorders is anticipated to drive the GI stool testing market’s expansion. Gastrointestinal disorders are conditions that impact the digestive system – including the stomach, intestines and associated organs – leading to symptoms like nausea, diarrhoea, constipation and stomach pain. These disorders are primarily stemming from unhealthy eating habits which lead to increased consumption of processed food, high sugar content, and low-fiber diets that disturb the gut microbiota, weaken the digestive health, and cause conditions like acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). Analyzing stool samples becomes crucial in diagnosing these gastrointestinal disorders as it helps to uncover infections, inflammation or digestive imbalances. Through this, pathogens (bacteria, viruses, parasites), signs of gut inflammation, and digestive enzyme deficiencies can be identified, thus allowing precise diagnosis and customised treatment. For example, in September 2024, it was reported by the Centers for Disease Control and Prevention, a US government agency, that the participating states of NoroSTAT reported 1,676 outbreaks of norovirus from 2024 to 2025, a significant increase from the 729 outbreaks noted during the same period in the previous season. Therefore, the rising occurrence of gastrointestinal disorders fuels the growth of the GI stool testing market.

Which Segments Define The Structure Of The GI Stool Testing Market?

The gi stool testingmarket covered in this report is segmented –

1) By Type: Immunoassay Test; Molecular Diagnostic Test; Chromatography-Based Test; Microbiological Culture Test; Enzyme-Linked Immunosorbent Assay (ELISA)

2) By Sample Type: Fecal Samples; Serum Samples

3) By Equipment: Automated Analyzers; Benchtop Instruments; Portable Devices

4) By Application: Diagnosis Of Gastrointestinal Disorders; Screening For Colorectal Cancer; Monitoring Of Inflammatory Bowel Disease (IBD); Detection Of Gastrointestinal Infections; Evaluation Of Digestive Health

5) By End User: Hospital; Diagnostic Centre And Laboratory; Academic Institution; Research Centre Organization; Homecare; Other End Users

Subsegments:

1) By Immunoassay Test: Rapid Immunoassay; Lateral Flow Assay; Fluorescent Immunoassay

2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Test (NAAT); Next-Generation Sequencing (NGS)

3) By Chromatography-Based Test: Gas Chromatography (GC); Liquid Chromatography (LC); Thin-Layer Chromatography (TLC)

4) By Microbiological Culture Test: Aerobic Culture; Anaerobic Culture; Selective Media Culture

5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA; Competitive ELISA

Which Disruptive Trends Are Driving Change Across The GI Stool Testing Market?

Leading businesses in the GI stool testing market are centralizing their attention on innovative testing techniques, such as extensive diagnostic tests, in order to amplify precision, rapidity, and early detection of ailments. An extensive diagnostic test is a cutting-edge medical instrument that concurrently examines several health parameters, providing a complete evaluation of a situation. For example, US-based diagnostics firm EmeritusDX released GI Detect, an extensive diagnostic test conceived to assist medical professionals to identify gastrointestinal disorders, in November 2024. This state-of-the-art test uses a single stool swab to identify 26 bacteria, viruses and parasites connected with digestive system perturbations. With a 24-hour turnaround time, GI Detect provides rapid and informed clinical decision-making. Besides widespread pathogen detection, the test also screens for Helicobacter pylori and its virulence constituents—VacA, cagA, and babA—along with prevalent gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This extensive strategy guarantees precise and timely diagnosis of gastrointestinal infections.

Who Are The Primary Market Leaders In The GI Stool Testing Market?

Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, Helena Laboratories Corporation, ELITechGroup, Genova Diagnostics Inc., Genesis Laboratory Management LLC, US BioTek Laboratories LLC, Doctor’s Data Inc., Diagnostic Solutions Laboratory LLC, Serosep Ltd., Atlas Laboratories Ltd., VDI Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, ScheBo Biotech AG.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report

What Regional Factors Are Accelerating Growth In The GI Stool Testing Market?

North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23410&type=smp

Browse Through More Reports Similar to the Global GI Stool Testing Market 2025, By The Business Research Company

Application Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/application-testing-services-global-market-report

Automation Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automation-testing-global-market-report

Bioanalytical Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioanalytical-testing-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model